Dr Andrew Care has been a member of Sydney Vital since 2017 and this year was awarded a 2018 Early Career Fellowship from the Cancer Institute NSW.
This will be the sixth Sydney Cancer Conference and is focusing on the theme of ‘Bridging research and practice,’ the program features all areas of cancer research – basic biomedical, public health, clinical and psychosocial – making the latest information and research available to delegates.
Sydney vital will be supporting up to ten attendees and applications are invited from suitably qualified researchers. Our aim is to encourage outstanding PhD students, ECRs, researchers and clinicians from within the Sydney Vital network and institutions to present their scientific research progress at national or international conferences.
Applications must complete the Sydney Vital Registration Support Form for the SCC2018 and must be submitted as a single PDF attachment in an email to [email protected]. Please use the following naming convention:
Once approved, Sydney Vital will complete payment of the successful applicants’ registration fee. Please note, we will not reimburse any payments that have been made prior to applying for registration support.
Applications will close on Friday 25th May 2018. Sydney Vital Centre Manager, Suzie Nguyen, can be contacted on 9926 4726 or at [email protected] to assist with any queries.
Sydney Vital is pleased to invite applications for its Seed Funding Awards to the value of $25,000 each. The Sydney Vital Seed Funding Scheme intends to seed new ideas, with the goal of generating data to a point where external funding may be sought. The ideas to be tested should be (i) new in concept and (ii) distinct from currently or previously funded research. Projects should focus on Translational Cancer Research and closely align with one or more of Sydney Vital’s Flagship Programs and/or Translational Cancer Research Centres (TCE) which are;
Breast Cancer Implementation
Sydney 1000 CRC
Call for Applications: 14 February 2018
Closing Date for Applications: 9th March 2018
Any queries should be directed to [email protected]
Applications are invited from suitably qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 3: Nanotechnology.
This is also to invite any of you interested in Translational Cancer Research to become a member of Sydney Vital.
Call for Applications: Tuesday 31st January 2017
Closing Date for Applications: Tuesday 27th February 2017
Announcement of Outcome aim at: Wednesday 15th March 2017
Please let us know if you have any further questions.
Email: [email protected] for general information regarding your application submission.
Email: Alexander Engel: [email protected] for specific question regarding the Flagship 3.
Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $10,000 each for one year, to students, preclinical and clinical researchers working in the area of Translational Cancer Research.
The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.
|1||Jerikho Bulanadi||Kolling Institute of Medical Research||Prof Ross Smith||Chemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.||$15,000|
|2||Emma Colvill||Sydney University Medical School||Prof Paul Keall||The bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer||$15,000|
|3||Grace Gifford||Haematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, Sydney||Dr William Stevenson||Gene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.||$15,000|
|4||Dr Anthony Glover||Kolling Institute of Medical Research, Royal North Shore Hospital||Prof Stanley Sidhu||Noncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.||$15,000|
|5||Diana Hatoum||Faculty of Science, UTS Sydney||Dr Najah Nassif||A Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.||$15,000|
|6||Samuel Brennan||Faculty of Science, UTS Sydney||Dr Rose Martiniello-Wilks||Development of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.||$15,000|
|7||Ben Harris||Sydney Medical School, University of Sydney||Dr Kellie Charles||Investigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.||$15,000|
|8||Adrian Lee||Bill Walsh Translation Cancer Research Laboratory, Kolling Institute||Dr Viive Howell||"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with|
|9||Jaynish Shah||Sydney Medical School, University of Sydney||Prof Deborah Marsh||Investigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?||$15,000|
Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $15,000 each for one year to students, preclinical and clinical researchers working in the area of Translational Cancer Research. These awards are to be used to support the research and are to be spent at the discretion of the student and their supervisor(s).
Key Dates for Round 3
Call for Applications: 1 September 2015
Closing Date for Applications: 1 October 2015
Announcement of Outcome: 1 November 2015